Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Sale

Global Drug Discovery and Development Solutions Market: By Service Type: Medicinal Chemistry, Biology Services, Others; By Drug Type; By Process; By Technology; By Mode; By Therapeutic Area; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Competitive Landscape; Industry Events and Developments

Global Drug Discovery and Development Solutions Market Outlook

The global drug discovery and development solutions market is expected to grow at a CAGR of 13% in the forecast period of 2021-2026.

 

North America to be a Significant Regional Market for the Drug Discovery and Development Solutions Industry

The global market for drug discovery and development solutions is significantly aided by the industry growth in North America. The development of the drug discovery outsourcing industry in the region could be attributed to an increase in emphasis on discovering medicines for the treatment of COVID-19, which has resulted in drug discovery outsourcing to companies equipped with AI technology. In addition, the growth in the investment in research and development (R&D) by major pharmaceutical and biotechnology firms and their emphasis on streamlining the internal costs of drug discovery outsourcing is fuelling the growth of the drug discovery and development solutions industry.

 

Drug Discovery and Development Solutions: Industry Definition and Segmentation

Drug discovery refers to the discovery of new medication and to the process of creating a therapeutically active substance for a particular target molecule or pathway. Drug discovery comprises of screening hits, medicinal chemistry, and optimisation of hits to reduce possible side effects of drugs. The discovery and development solutions of drugs together is a full process of identifying and introducing a new medication in the market.

The service types in the market can be divided into the following:

The drug types in the market can be divided into small molecules and biologics. The process types can be segmented as:

  • Target Selection
  • Target Validation
  • Hit-To-Lead Identification
  • Lead Optimisation
  • Candidate Validation
  • Others

The technology types in the industry can be segmented into the following:

  • High Throughput Screening
  • Biochips
  • Pharmacogenetics
  • Nanotechnology
  • Spectroscopy
  • Others

Based on therapeutic area, the market can be segmented into:

  • Oncology
  • Neurology
  • Infectious and Immune System Diseases
  • Digestive System Diseases
  • Cardiovascular Diseases
  • Others

The regional markets for drug discovery and development solutions can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Rising R&D Activities in the Pharmaceuticals Sector Bolstering the Market Growth for Drug Discovery and Development Solutions 

The expansion of the demand for drug discovery outsourcing can be attributed to an increase in the emphasis on discovering medicines for the treatment of the rising COVID-19 pandemic, which has resulted in drug discovery outsourcing to companies equipped with AI technology. In addition, the growth in the investment in research and development (R&D) by major pharmaceutical and biotechnology firms and their emphasis on streamlining the internal costs of drug discovery outsourcing is fuelling the market growth. Developments in fundamental algorithms are used in computational information processing for predictive chemistry, which leads to improvements in scientific innovation and laboratory informatics. This is likely to increase the demand in the market in the coming years.

 

Key Industry Players in the Global Drug Discovery and Development Solutions Market

The report gives a detailed analysis of the following key players in the global drug discovery and development solutions market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Abbott Laboratories Inc.
  • AstraZeneca plc
  • Genentech, USA Inc
  • Charles River Laboratories International, Inc.
  • Gilead Sciences, Inc.
  • Pfizer Inc.
  • Jubilant Biosys Ltd.
  • Sanofi SA
  • F. Hoffmann-La Roche Ltd
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description
    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary
    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Drug Discovery and Development Solutions Market Analysis
    8.1    Key Industry Highlights
    8.2    Global Drug Discovery and Development Solutions Historical Market (2016-2020) 
    8.3    Global Drug Discovery and Development Solutions Market Forecast (2021-2026)
    8.4    Global Drug Discovery and Development Solutions Market by Service Type
        8.4.1    Medicinal Chemistry
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Biology Services
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Drug Metabolism 
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
        8.4.4    Pharmaceutical Services
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2016-2020)
            8.4.4.3    Forecast Trend (2021-2026)
        8.4.5    Pharmacokinetics
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2016-2020)
            8.4.5.3    Forecast Trend (2021-2026)
        8.4.6    Others
    8.5    Global Drug Discovery and Development Solutions Market by Drug Type
        8.5.1    Small Molecules
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Biologics
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
    8.6    Global Drug Discovery and Development Solutions Market by Process
        8.6.1    Target Selection
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Target Validation
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Hit-To-Lead Identification
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
        8.6.4    Lead Optimisation
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2016-2020)
            8.6.4.3    Forecast Trend (2021-2026)
        8.6.5    Candidate Validation
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2016-2020)
            8.6.5.3    Forecast Trend (2021-2026)
        8.6.6    Others
    8.7    Global Drug Discovery and Development Solutions Market by Technology
        8.7.1    High Throughput Screening
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2016-2020)
            8.7.1.3    Forecast Trend (2021-2026)
        8.7.2    Biochips
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2016-2020)
            8.7.2.3    Forecast Trend (2021-2026)
        8.7.3    Pharmacogenetics
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2016-2020)
            8.7.3.3    Forecast Trend (2021-2026)
        8.7.4    Nanotechnology
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2016-2020)
            8.7.4.3    Forecast Trend (2021-2026)
        8.7.5    Spectroscopy
            8.7.5.1    Market Share
            8.7.5.2    Historical Trend (2016-2020)
            8.7.5.3    Forecast Trend (2021-2026)
        8.7.6    Others
    8.8    Global Drug Discovery and Development Solutions Market by Mode
        8.8.1    In-house
            8.8.1.1    Market Share
            8.8.1.2    Historical Trend (2016-2020)
            8.8.1.3    Forecast Trend (2021-2026)
        8.8.2    Outsourced
            8.8.2.1    Market Share
            8.8.2.2    Historical Trend (2016-2020)
            8.8.2.3    Forecast Trend (2021-2026)
    8.9    Global Drug Discovery and Development Solutions Market by Therapeutic Area
        8.9.1    Oncology
            8.9.1.1    Market Share
            8.9.1.2    Historical Trend (2016-2020)
            8.9.1.3    Forecast Trend (2021-2026)
        8.9.2    Neurology
            8.9.2.1    Market Share
            8.9.2.2    Historical Trend (2016-2020)
            8.9.2.3    Forecast Trend (2021-2026)
        8.9.3    Infectious and Immune System Diseases
            8.9.3.1    Market Share
            8.9.3.2    Historical Trend (2016-2020)
            8.9.3.3    Forecast Trend (2021-2026)
        8.9.4    Digestive System Diseases
            8.9.4.1    Market Share
            8.9.4.2    Historical Trend (2016-2020)
            8.9.4.3    Forecast Trend (2021-2026)
        8.9.5    Cardiovascular Diseases
            8.9.5.1    Market Share
            8.9.5.2    Historical Trend (2016-2020)
            8.9.5.3    Forecast Trend (2021-2026)
        8.9.6    Others
    8.10    Global Drug Discovery and Development Solutions Market by End Use
        8.10.1    Hospital & Clinics
            8.10.1.1    Market Share
            8.10.1.2    Historical Trend (2016-2020)
            8.10.1.3    Forecast Trend (2021-2026)
        8.10.2    Pharmaceutical Companies
            8.10.2.1    Market Share
            8.10.2.2    Historical Trend (2016-2020)
            8.10.2.3    Forecast Trend (2021-2026)
        8.10.3    Biotechnology Companies
            8.10.3.1    Market Share
            8.10.3.2    Historical Trend (2016-2020)
            8.10.3.3    Forecast Trend (2021-2026)
        8.10.4    Research Institute
            8.10.4.1    Market Share
            8.10.4.2    Historical Trend (2016-2020)
            8.10.4.3    Forecast Trend (2021-2026)
        8.10.5    Others
    8.11    Global Drug Discovery and Development Solutions Market by Region
        8.11.1    Market Share
            8.11.1.1    North America
            8.11.1.2    Europe
            8.11.1.3    Asia Pacific
            8.11.1.4    Latin America
            8.11.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape
    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Abbott Laboratories Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    AstraZeneca plc
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Genentech, USA Inc
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Charles River Laboratories International, Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Gilead Sciences, Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Pfizer Inc.
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Jubilant Biosys Ltd.
            12.2.7.1    Company Overview
            12.2.7.2    Product Portfolio
            12.2.7.3    Demographic Reach and Achievements
            12.2.7.4    Certifications
        12.2.8    Sanofi SA
            12.2.8.1    Company Overview
            12.2.8.2    Product Portfolio
            12.2.8.3    Demographic Reach and Achievements
            12.2.8.4    Certifications
        12.2.9    F. Hoffmann-La Roche Ltd
            12.2.9.1    Company Overview
            12.2.9.2    Product Portfolio
            12.2.9.3    Demographic Reach and Achievements
            12.2.9.4    Certifications
        12.2.10    Others
13    Industry Events and Developments

1.    Global Drug Discovery and Development Solutions Market: Key Industry Highlights, 2016 and 2026
2.    Global Drug Discovery and Development Solutions Historical Market: Breakup by Service Type (USD Billion), 2016-2020
3.    Global Drug Discovery and Development Solutions Market Forecast: Breakup by Service Type (USD Billion), 2021-2026
4.    Global Drug Discovery and Development Solutions Historical Market: Breakup by Drug Type (USD Billion), 2016-2020
5.    Global Drug Discovery and Development Solutions Market Forecast: Breakup by Drug Type (USD Billion), 2021-2026
6.    Global Drug Discovery and Development Solutions Historical Market: Breakup by Process (USD Billion), 2016-2020
7.    Global Drug Discovery and Development Solutions Market Forecast: Breakup by Process (USD Billion), 2021-2026
8.    Global Drug Discovery and Development Solutions Historical Market: Breakup by Technology (USD Billion), 2016-2020
9.    Global Drug Discovery and Development Solutions Market Forecast: Breakup by Technology (USD Billion), 2021-2026
10.    Global Drug Discovery and Development Solutions Historical Market: Breakup by Mode (USD Billion), 2016-2020
11.    Global Drug Discovery and Development Solutions Market Forecast: Breakup by Mode (USD Billion), 2021-2026
12.    Global Drug Discovery and Development Solutions Historical Market: Breakup by Therapeutical Area (USD Billion), 2016-2020
13.    Global Drug Discovery and Development Solutions Market Forecast: Breakup by Therapeutical Area (USD Billion), 2021-2026
14.    Global Drug Discovery and Development Solutions Historical Market: Breakup by End Use (USD Billion), 2016-2020
15.    Global Drug Discovery and Development Solutions Market Forecast: Breakup by End Use (USD Billion), 2021-2026
16.    Global Drug Discovery and Development Solutions Historical Market: Breakup by Region (USD Billion), 2016-2020
17.    Global Drug Discovery and Development Solutions Market Forecast: Breakup by Region (USD Billion), 2021-2026
18.    North America Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2016-2020
19.    North America l Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2021-2026
20.    Europe Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2016-2020
21.    Europe Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2021-2026
22.    Asia Pacific Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2016-2020
23.    Asia Pacific Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2021-2026
24.    Latin America Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2016-2020
25.    Latin America Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2021-2026
26.    Middle East and Africa Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2016-2020
27.    Middle East and Africa Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2021-2026
28.    Global Drug Discovery and Development Solutions Market Structure

Key Questions Answered in the Report

What is the growth rate of the global drug discovery and development solutions market?

The global drug discovery and development solutions market is projected to grow at a CAGR of 13% between 2021 and 2026.

What are the major market drivers?

The growth of the market is being driven by growing population, rising healthcare sector, increasing disposable incomes, growing R&D activities, and the rising pharmaceuticals sector.

What are the key industry trends of the global drug discovery and development solutions market?

The increasing focus on discovering medicines for the treatment of COVID-19 is an important industry trend guiding the growth of the market.

What are the major regional markets of drug discovery and development solutions, according to the EMR report?

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

What are the leading service types in the market?

The leading service types in the market are medicinal chemistry, biology services, drug metabolism, pharmaceutical services, and pharmacokinetics, among others.

What are the major drug types in the industry?

The major drug types in the industry are small molecules and biologics.

What are the significant process types in the market?

The significant process types in the market are target selection, target validation, hit-to-lead identification, lead optimisation, and candidate validation, among others.

What are the leading technology types in the industry?

The leading technology types in the industry are high throughput screening, biochips, pharmacogenetics, nanotechnology, and spectroscopy, among others.

What are the major therapeutic areas in the market?

The major therapeutic areas in the market are oncology, neurology, infectious and immune system diseases, digestive system diseases, and cardiovascular diseases, among others.

Who are the key industry players, according to the report?

The major players in the industry are Abbott Laboratories Inc., AstraZeneca plc, Genentech, USA Inc, Charles River Laboratories International, Inc., Gilead Sciences, Inc., Pfizer Inc., Jubilant Biosys Ltd., Sanofi SA, and F. Hoffmann-La Roche Ltd, among others.

Analyst Review

The global drug discovery and development solutions market is being driven by the rising healthcare sector. Aided by the growing R&D activities, the market is expected to witness a robust growth in the forecast period of 2021-2026, growing at a CAGR of 13%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on service types, the market is segmented into medicinal chemistry, biology services, drug metabolism, pharmaceutical services, and pharmacokinetics, among others. On the basis of drug type, the industry is bifurcated into small molecules and biologics. By process types, the market is categorised into target selection, target validation, hit-to-lead identification, lead optimisation, and candidate validation, among others. Based on technology type, the industry is segmented into high throughput screening, biochips, pharmacogenetics, nanotechnology, and spectroscopy, among others. On the basis of therapeutic area, the market is divided into oncology, neurology, infectious and immune system diseases, digestive system diseases, and cardiovascular diseases, among others. The major regional markets for drug discovery and development solutions are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abbott Laboratories Inc., AstraZeneca plc, Genentech, USA Inc, Charles River Laboratories International, Inc., Gilead Sciences, Inc., Pfizer Inc., Jubilant Biosys Ltd., Sanofi SA, and F. Hoffmann-La Roche Ltd, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Sale

Global Radiodermatitis Market Report and Forecast 2021-2026

  • 24 Hour Email Delivery
  • Price: $  1999   $ 1499
Radiodermatitis Market Size, Share, Analysis, Growth, Report 2021-2026
Read More

Sale

Global Parkinson’s Disease Drugs Market Report and Forecast 2021-2026

  • 24 Hour Email Delivery
  • Price: $  1999   $ 1499
Parkinson’s Disease Drugs Market Size, Share, Growth, Report 2021-2026
Read More

Sale

Global Veterinary Drugs Market Report and Forecast 2021-2026

  • 24 Hour Email Delivery
  • Price: $  1999   $ 1499
Veterinary Drugs Market Size, Share, Report and Forecast 2021-2026
Read More

Sale

Global Cardiovascular Drugs Market Report and Forecast 2021-2026

  • 24 Hour Email Delivery
  • Price: $  1999   $ 1499
Cardiovascular Drugs Market Size, Share, Price, Trends, Report 2021-2026
Read More

Sale

Global Prothrombin Complex Concentrate (PCC) Market Report and Forecast 2021-2026

  • 24 Hour Email Delivery
  • Price: $  1999   $ 1499
Prothrombin Complex Concentrate (PCC) Market Size, Share, Report 2021-2026
Read More
NEWSLETTER